All Stories

  1. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial

    Article • Diabetes and Vascular Disease Research, April 2017, SAGE Publications

    Dr Aslak Rautio

  2. Fibrinolysis and peripheral arterial disease in diabetes

    Article • Diabetes and Vascular Disease Research, January 2016, SAGE Publications

    Dr Aslak Rautio

  3. Favorable Trends in the Incidence and Outcome in Stroke in Nondiabetic and Diabetic Subjects: Findings From the Northern Sweden MONICA Stroke Registry in 1985 to 2003

    Article • Stroke, August 2008, Wolters Kluwer Health

    Dr Aslak Rautio

  4. Favourable trends in the incidence and outcome of myocardial infarction in nondiabetic, but not in diabetic, subjects: findings from the MONICA myocardial infarction registry in northern Sweden in 1989-2000

    Article • Journal of Internal Medicine, October 2005, Wiley

    Dr Aslak Rautio

  5. Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction

    Article • Journal of Internal Medicine, July 2005, Wiley

    Dr Aslak Rautio